Posters

Game changing RNA delivery platform for next generation therapy : FlashRNA® (ESGCT 2023)

Gene editing on primary & stem cells using LentiFlash (FlashRNA®) RNA delivery approach (ASGCT 2022)

NK cells engineering using advanced Lentiviral Vectors quality and design (EBMT 2023)

GMP platform for lentiviral vector production with 9000 batches produced (Advanced Therapies 2023)

Lentivirus Manufacturing : successful & reproducible continuum process from research batches to clinical application (ISCT 2023)

Next Generation Therapy : RNA delivery by LentiFlash (FlashRNA®) for an efficient CRISPR/Cas9-mediated gene knockout in Human iPS (EBMT 2023)

Efficient & safe delivery of multiple mRNA using non-integrative bacteriophage-chimeric retrovirus-like particles for in vivo application (ASGCT 2022)

All-in-one delivery using LentiFlash (FlashRNA®) for clinical application (ESGCT 2019)

All-in-one Delivery Using LentiFlash® technology, a MS2-chimeric RNA Delivery Tool Designed for Clinical Applications (ASGCT 2019)

Primary cells and in vivo immunomodulation using LentiFlash®, a chimeric RNA delivery technology designed for clinical applications